SCHEMBL17126865

SCHEMBL17126865

CCCOc1ccc(Oc2ccc(C(=O)C(SCCOCC)C(C)(C)C)c3ccccc23)c(OCCC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 5/20 0.41
▸ CNR2 P34972 5/20 0.41
▸ CYP2C9 P11712 1/20 0.36
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ PNLIP P16233 1/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ PTGES O14684 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ PPARG P37231 1/20 0.33
▸ THRA P10827 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ ADRB1 P08588 1/20 0.32
▸ ADRB3 P13945 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127330 0.91 CNR1 (0.41) CNR1CNR2CYP2C9LMNAMAPT
SCHEMBL17126858 0.91 CNR1 (0.41) CNR1CNR2CYP2C9LMNAMAPT
SCHEMBL17127331 0.90 CNR2 (0.42) CNR1CNR2CYP2C9PNLIPFFAR1
SCHEMBL17126857 0.88 APP (0.36) LMNAMAPTFFAR1L3MBTL1MEN1
SCHEMBL17126861 0.84 CNR1 (0.39) CNR1CNR2CYP2C9FFAR1PPARG
SCHEMBL17127352 0.84 FFAR1 (0.39) CNR1CNR2CYP2C9LMNAMAPT
SCHEMBL17127328 0.82 CDC25B (0.37) CNR1CNR2LMNAMAPTFFAR1
SCHEMBL17127023 0.76 KDM4E (0.37) LMNAMAPTL3MBTL1MEN1HTT
SCHEMBL17126863 0.74 ACACB (0.37) LMNAMAPTTHRAL3MBTL1ADRB1
SCHEMBL17126856 0.73 SMN1; SMN2 (0.33) LMNAMAPTPPARGL3MBTL1ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS CNR1 4336/4885CNR2 4651/4885CYP2C9 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback